Search or choose
Find the right test or package.
17p Deletion, Blood
This test is used to detect the deletion (loss of heterozygosity) of the tumor-suppressor gene TP53, which can be seen in Plasma cell myeloma or CLL. This assay is useful to provide an estimate of the prognosis (aggressiveness of disease) of B-cell Chronic lym...
DiagnosticsLab test
Know more about this test
This test is used to detect the deletion (loss of heterozygosity) of the tumor-suppressor gene TP53, which can be seen in Plasma cell myeloma or CLL. This assay is useful to provide an estimate of the prognosis (aggressiveness of disease) of B-cell C...
Understanding 17p Deletion, Blood
This test is used to detect the deletion (loss of heterozygosity) of the tumor-suppressor gene TP53, which can be seen in Plasma cell myeloma or CLL. This assay is useful to provide an estimate of the prognosis (aggressiveness of disease) of B-cell Chronic lymphocytic leukemia (B-CLL) and to help evaluate treatment options.
What does 17p Deletion, Blood measure?
This test is used to detect the deletion (loss of heterozygosity) of the tumor-suppressor gene TP53, which can be seen in Plasma cell myeloma or CLL. This assay is useful to provide an estimate of the prognosis (aggressiveness of disease) of B-cell Chronic lymphocytic leukemia (B-CLL) and to help evaluate treatment options.
Related parameters
How does home sample collection work?
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.